Role of Smad3 inhibitor and the pyroptosis pathway in spinal cord injury

  • Zhu J
  • Fu Y
  • Tu G
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

The aim of the present study was to investigate the role of Smad3 inhibitors and the pyroptosis pathway in spinal cord injury, and to determine the underlying mechanism. The pyroptosis signaling pathway may be involved in spinal cord injury during the recovery period. Smad3 inhibitor may serve a role in alleviating spinal cord injury by reducing the pyroptosis of neurons, which is induced by caspase-1, absent in melanoma-2 or NOD-like receptors protein-1 during the recovery period of spinal cord injury. In the present study, spinal cord injury was alleviated by caspase-1 and Smad3 inhibitors. Therefore, a Smad3 inhibitor could relieve spinal cord injury in mice by directly downregulating caspase-1 and reducing neuron pyroptosis following spinal cord injury during the recovery period.

Cite

CITATION STYLE

APA

Zhu, J., Fu, Y., & Tu, G. (2020). Role of Smad3 inhibitor and the pyroptosis pathway in spinal cord injury. Experimental and Therapeutic Medicine, 20(2), 1675–1681. https://doi.org/10.3892/etm.2020.8832

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free